Antonio Fernando Ribeiro
Overview
Explore the profile of Antonio Fernando Ribeiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martins-Duarte P, Hessel G, Ribeiro A, Marson F, Colella-Santos M
J Pediatr (Rio J)
. 2024 Sep;
101(1):96-102.
PMID: 39245235
Objective: This study aims to evaluate the central auditory system of children and adolescents with cystic fibrosis through behavioral assessment of central auditory processing and electrophysiological tests to investigate short...
2.
Procianoy E, Ludwig Neto N, Ribeiro A
J Bras Pneumol
. 2023 Feb;
49(1):e20220306.
PMID: 36753213
Objective: To analyze the characteristics of cystic fibrosis (CF) care centers (CFCCs) in Brazil. Methods: A questionnaire was sent to the coordinators of all 51 registered CFCCs between May and...
3.
Goncalves E, Ribeiro J, Marson F, Montes C, Ribeiro A, Mainz J, et al.
J Pediatr (Rio J)
. 2022 Dec;
99(3):269-277.
PMID: 36564006
Objective: To assess the prevalence of GERD exclusively by means of multichannel intraluminal impedanciometry associated with pH monitoring (MIIpH) and compare it with respiratory symptoms in children with CF. To...
4.
Zorron M, Marson F, Morcillo A, Goncalves A, El Beck M, Ribeiro J, et al.
J Bras Pneumol
. 2022 Apr;
48(2):e20210307.
PMID: 35475864
Objective: To determine whether abnormal continuous glucose monitoring (CGM) readings (hypoglycemia/hyperglycemia) can predict the onset of cystic fibrosis-related diabetes (CFRD) and/or clinical impairment (decline in BMI and/or FEV1) in pediatric...
5.
Sandy N, Furlaneto Marega L, Bechara G, Riccetto A, Bonfim C, Dos Santos Vilela M, et al.
Rev Paul Pediatr
. 2021 Nov;
40:e2020434.
PMID: 34730757
Objective: To report two patients with very-early-onset inflammatory bowel disease (VEOIBD) secondary to interleukin-10 receptor (IL-10R) mutations, explore immunophenotyping data and plasma cytokine profile on these cases compared to healthy...
6.
Stefano M, Sandy N, Zagoya C, Duckstein F, Ribeiro A, Mainz J, et al.
J Cyst Fibros
. 2021 Sep;
21(3):497-501.
PMID: 34511390
No abstract available.
7.
Souza Gomez C, Parazzi P, Clinckspoor K, Mauch R, Pessine F, Levy C, et al.
Clin Drug Investig
. 2019 Nov;
40(2):105-117.
PMID: 31721070
Background: Among the many consequences of loss of CFTR protein function, a significant reduction of the secretion of bicarbonate (HCO) in cystic fibrosis (CF) is a major pathogenic feature. Loss...
8.
Gobato A, Vasques A, Ribeiro A, Yamada R, Hessel G
Rev Paul Pediatr
. 2019 Jun;
37(4):435-441.
PMID: 31241693
Objective: To determine the prevalence of hepatic steatosis (HS) in children and adolescents with cystic fibrosis (CF) and associate it with nutritional status. Methods: Cross-sectional study with children and adolescents...
9.
Pereira S, Ribeiro J, Ribeiro A, Bertuzzo C, Marson F
Sci Rep
. 2019 Apr;
9(1):6234.
PMID: 30996306
Cystic fibrosis (CF) is caused by ~300 pathogenic CFTR variants. The heterogeneity of which, challenges molecular diagnosis and precision medicine approaches in CF. Our objective was to identify CFTR variants...
10.
Kmit A, Marson F, Pereira S, Vinagre A, Leite G, Servidoni M, et al.
Biochim Biophys Acta Mol Basis Dis
. 2019 Feb;
1865(6):1323-1331.
PMID: 30716472
Background: We analyzed the CFTR response to VX-809/VX-770 drugs in conditionally reprogrammed cells (CRC) of human nasal epithelium (HNE) from F508del/F508del patients based on SNP rs7512462 in the Solute Carrier...